Download PDF
Thromb Haemost 2018; 118(08): 1461-1469
DOI: 10.1055/s-0038-1666858
Atherosclerosis and Ischaemic Disease
Georg Thieme Verlag KG Stuttgart · New York

No Association between Thrombin Generation and Intra-Plaque Haemorrhage in Symptomatic Carotid Atherosclerotic Plaques: The Plaque at RISK (PARISK) Study

Geneviève A. J. C. Crombag
1   Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
2   CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
,
Henri M. Spronk
2   CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
3   Department of Internal Medicine, Clinical Thrombosis and Haemostasis Laboratory, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
,
Patty Nelemans
4   Department of Epidemiology, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
,
Floris H. B. M. Schreuder
5   Department of Neurology, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
6   Department of Clinical Neurophysiology, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
,
Martine T. B. Truijman
5   Department of Neurology, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
6   Department of Clinical Neurophysiology, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
,
Anouk C. van Dijk
7   Department of Radiology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands
8   Department of Neurology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands
,
Alexandra A. J. de Rotte
9   Department of Radiology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands
,
Madieke I. Liem
10   Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
,
Mat J. A. P. Daemen
11   Department of Pathology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
,
Anton F. W. van der Steen
12   Department of Biomedical Engineering, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands
,
Werner H. Mess
2   CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
6   Department of Clinical Neurophysiology, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
,
Paul J. Nederkoorn
10   Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
,
Jeroen Hendrikse
9   Department of Radiology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands
,
Aad van der Lugt
7   Department of Radiology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands
,
Joachim E. Wildberger
1   Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
2   CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
,
Hugo ten Cate
2   CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
3   Department of Internal Medicine, Clinical Thrombosis and Haemostasis Laboratory, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
,
Robert J. van Oostenbrugge
2   CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
4   Department of Epidemiology, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
,
M. Eline Kooi
1   Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
2   CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands
› Author Affiliations Funding This research was performed within the framework of CTMM, project PARISk (grant 01C-202), and supported by the Dutch Heart Foundation. This project has received funding from the European Union (EU) Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 722609.
Further Information

Publication History

03 November 2017

20 May 2018

Publication Date:
04 July 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Background Carotid atherosclerosis is an important cause of stroke. Intra-plaque haemorrhage (IPH) on magnetic resonance imaging (MRI) increases stroke risk. Development of IPH is only partly understood. Thrombin is an essential enzyme in haemostasis. Experimental animal studies have shown conflicting results on the relation between thrombin and plaque vulnerability. We hypothesize that decreased thrombin generation (TG) is associated with IPH and plaque vulnerability.

Objective This article investigates whether TG is associated with IPH and other features of plaque vulnerability in stroke patients.

Methods Recently symptomatic stroke patients underwent carotid MRI and blood sampling. MRI plaque features include plaque burden, presence of IPH, amount of lipid-rich necrotic core (LRNC), calcified tissue and fibrous tissue (% of total wall volume). TG was assessed in platelet-poor plasma and expressed as: peak height (PH) and endogenous thrombin potential (ETP). MR images could be analysed in 224 patients. Blood samples were available in 161 of 224 patients. Binary multivariate logistic and linear regression were used to investigate the association between TG and MRI plaque features.

Results IPH and LRNC were present in 65 (40%) and 102 (63%) of plaques. There were no significant associations between TG and IPH; PH odds ratio (OR) = 1, 95% confidence interval (CI): 0.76 to 1.45 and ETP OR = 1, 95% CI: 0.73 to 1.37. After correction for age, sex and hypercholesterolaemia, the association was weak but non-significant; PH: OR = 0.76, 95% CI: 0.52 to 1.10 and ETP: OR = 0.73, 95% CI: 0.53 to 1.37.

Conclusion Features of carotid plaque on MRI show no significant association with TG in stroke patients. Systemic TG does not seem to be an important factor in IPH development.

Keywords

carotid stenosis - ischaemic attack - transient - magnetic resonance imaging - stroke - thrombin

Note

ClinicalTrials.gov Identifier, NCT Number: NCT01208025.


 

  • References

  • 1 Chaturvedi S, Bruno A, Feasby T. , et al; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Carotid endarterectomy—an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005; 65 (06) 794-801
    CrossrefPubMedGoogle Scholar
  • 2 Rothwell PM, Eliasziw M, Gutnikov SA. , et al; Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361 (9352): 107-116
    CrossrefPubMedGoogle Scholar
  • 3 Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res 2014; 114 (12) 1852-1866
    CrossrefPubMedGoogle Scholar
  • 4 Joshi FR, Lindsay AC, Obaid DR, Falk E, Rudd JH. Non-invasive imaging of atherosclerosis. Eur Heart J Cardiovasc Imaging 2012; 13 (03) 205-218
    CrossrefPubMedGoogle Scholar
  • 5 Kwee RM, van Oostenbrugge RJ, Hofstra L. , et al. Identifying vulnerable carotid plaques by noninvasive imaging. Neurology 2008; 70 (24 Pt 2): 2401-2409
    CrossrefPubMedGoogle Scholar
  • 6 Saam T, Hatsukami TS, Takaya N. , et al. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 2007; 244 (01) 64-77
    CrossrefPubMedGoogle Scholar
  • 7 Yuan C, Mitsumori LM, Beach KW, Maravilla KR. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology 2001; 221 (02) 285-299
    CrossrefPubMedGoogle Scholar
  • 8 Cappendijk VC, Cleutjens KB, Heeneman S. , et al. In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging 2004; 20 (01) 105-110
    CrossrefPubMedGoogle Scholar
  • 9 Kwee RM, Schreuder FH, Mess WH. , et al. Images in cardiovascular medicine: development of carotid intraplaque hemorrhage demonstrated by serial magnetic resonance imaging. Circulation 2009; 120 (16) 1637-1639
    CrossrefPubMedGoogle Scholar
  • 10 Takaya N, Yuan C, Chu B. , et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005; 111 (21) 2768-2775
    Google Scholar
  • 11 Kwee RM, van Oostenbrugge RJ, Mess WH. , et al. MRI of carotid atherosclerosis to identify TIA and stroke patients who are at risk of a recurrence. J Magn Reson Imaging 2013; 37 (05) 1189-1194
    CrossrefPubMedGoogle Scholar
  • 12 Gupta A, Baradaran H, Schweitzer AD. , et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke 2013; 44 (11) 3071-3077
    CrossrefPubMedGoogle Scholar
  • 13 Saam T, Hetterich H, Hoffmann V. , et al. Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol 2013; 62 (12) 1081-1091
    CrossrefPubMedGoogle Scholar
  • 14 Hosseini AA, Kandiyil N, Macsweeney ST, Altaf N, Auer DP. Carotid plaque hemorrhage on magnetic resonance imaging strongly predicts recurrent ischemia and stroke. Ann Neurol 2013; 73 (06) 774-784
    CrossrefPubMedGoogle Scholar
  • 15 Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20 (05) 1262-1275
    Google Scholar
  • 16 Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310 (18) 1137-1140
    CrossrefPubMedGoogle Scholar
  • 17 Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013; 34 (10) 719-728
    CrossrefPubMedGoogle Scholar
  • 18 Michel JB, Martin-Ventura JL, Nicoletti A, Ho-Tin-Noé B. Pathology of human plaque vulnerability: mechanisms and consequences of intraplaque haemorrhages. Atherosclerosis 2014; 234 (02) 311-319
    CrossrefPubMedGoogle Scholar
  • 19 Duguid JB. The thrombogenic hypothesis and its implications. Postgrad Med J 1960; 36: 226-229
    CrossrefPubMedGoogle Scholar
  • 20 Davies MJ, Thomas AC. Plaque fissuring—the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985; 53 (04) 363-373
    CrossrefPubMedGoogle Scholar
  • 21 Daemen MJ, Ferguson MS, Gijsen FJ. , et al. Carotid plaque fissure: an underestimated source of intraplaque hemorrhage. Atherosclerosis 2016; 254: 102-108
    CrossrefPubMedGoogle Scholar
  • 22 Liem MI, Schreuder FH, van Dijk AC. , et al. Use of antiplatelet agents is associated with intraplaque hemorrhage on carotid magnetic resonance imaging: the Plaque at Risk Study. Stroke 2015; 46 (12) 3411-3415
    CrossrefPubMedGoogle Scholar
  • 23 Li X, Vink A, Niessen HW. , et al. Total burden of intraplaque hemorrhage in coronary arteries relates to the use of coumarin-type anticoagulants but not platelet aggregation inhibitors. Virchows Arch 2014; 465 (06) 723-729
    CrossrefPubMedGoogle Scholar
  • 24 Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood 2005; 106 (08) 2605-2612
    CrossrefPubMedGoogle Scholar
  • 25 Borissoff JI, Spronk HM, Heeneman S, ten Cate H. Is thrombin a key player in the ‘coagulation-atherogenesis’ maze?. Cardiovasc Res 2009; 82 (03) 392-403
    CrossrefPubMedGoogle Scholar
  • 26 Hemker HC, Giesen P, Al Dieri R. , et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33 (01) 4-15
    CrossrefPubMedGoogle Scholar
  • 27 Pingel S, Tiyerili V, Mueller J, Werner N, Nickenig G, Mueller C. Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice. Arch Med Sci 2014; 10 (01) 154-160
    CrossrefPubMedGoogle Scholar
  • 28 Preusch MR, Ieronimakis N, Wijelath ES. , et al. Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice. Drug Des Devel Ther 2015; 9: 5203-5211
    PubMedGoogle Scholar
  • 29 Bea F, Kreuzer J, Preusch M. , et al. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006; 26 (12) 2787-2792
    CrossrefPubMedGoogle Scholar
  • 30 Kadoglou NP, Moustardas P, Katsimpoulas M. , et al. The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice: dabigatran etexilate and atherosclerosis. Cardiovasc Drugs Ther 2012; 26 (05) 367-374
    CrossrefPubMedGoogle Scholar
  • 31 Borissoff JI, Otten JJ, Heeneman S. , et al. Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner. PLoS One 2013; 8 (02) e55784
    Google Scholar
  • 32 Seehaus S, Shahzad K, Kashif M. , et al. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability. Circulation 2009; 120 (09) 774-784
    CrossrefPubMedGoogle Scholar
  • 33 Carcaillon L, Alhenc-Gelas M, Bejot Y. , et al. Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study. Arterioscler Thromb Vasc Biol 2011; 31 (06) 1445-1451
    CrossrefPubMedGoogle Scholar
  • 34 Loeffen R, Winckers K, Ford I. , et al; PROSPER Study Group. Associations between thrombin generation and the risk of cardiovascular disease in elderly patients: results from the PROSPER Study. J Gerontol A Biol Sci Med Sci 2015; 70 (08) 982-988
    CrossrefPubMedGoogle Scholar
  • 35 Borissoff JI, Heeneman S, Kilinç E. , et al. Early atherosclerosis exhibits an enhanced procoagulant state. Circulation 2010; 122 (08) 821-830
    CrossrefPubMedGoogle Scholar
  • 36 Truijman MTB, Kooi ME, van Dijk AC. , et al. Plaque At RISK (PARISK): prospective multicenter study to improve diagnosis of high-risk carotid plaques. Int J Stroke 2014; 9 (06) 747-754
    CrossrefPubMedGoogle Scholar
  • 37 Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351 (9113): 1379-1387
    CrossrefPubMedGoogle Scholar
  • 38 Dielis AW, Balliël WM, van Oerle R. , et al. Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A. Haematologica 2008; 93 (09) 1351-1357
    CrossrefPubMedGoogle Scholar
  • 39 Elkind MS, Sacco RL. Stroke risk factors and stroke prevention. Semin Neurol 1998; 18 (04) 429-440
    Article in Thieme ConnectPubMedGoogle Scholar
  • 40 Derksen WJ, Peeters W, Tersteeg C. , et al. Age and coumarin-type anticoagulation are associated with the occurrence of intraplaque hemorrhage, while statins are associated less with intraplaque hemorrhage: a large histopathological study in carotid and femoral plaques. Atherosclerosis 2011; 214 (01) 139-143
    CrossrefPubMedGoogle Scholar
  • 41 Aburahma AF, Robinson P, Decanio R. Prospective clinicopathologic study of carotid intraplague hemorrhage. Am Surg 1989; 55 (03) 169-173
    PubMedGoogle Scholar
  • 42 AbuRahma AF, Boland JP, Robinson P, Decanio R. Antiplatelet therapy and carotid plaque hemorrhage and its clinical implications. J Cardiovasc Surg (Torino) 1990; 31 (01) 66-70
    PubMedGoogle Scholar
  • 43 With Notø AT, Mathiesen EB, Østerud B, Amiral J, Vissac AM, Hansen JB. Increased thrombin generation in persons with echogenic carotid plaques. Thromb Haemost 2008; 99 (03) 602-608
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Spronk HMH, Dielis AWJH, De Smedt E. , et al. Assessment of thrombin generation II: validation of the calibrated automated thrombogram in platelet-poor plasma in a clinical laboratory. Thromb Haemost 2008; 100 (02) 362-364
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 Ten Cate H. Thrombin generation in clinical conditions. Thromb Res 2012; 129 (03) 367-370
    CrossrefPubMedGoogle Scholar
  • 46 Kalz J, ten Cate H, Spronk HM. Thrombin generation and atherosclerosis. J Thromb Thrombolysis 2014; 37 (01) 45-55
    CrossrefPubMedGoogle Scholar
  • 47 Ten Cate H, Hemker HC. Thrombin generation and atherothrombosis: what does the evidence indicate?. J Am Heart Assoc 2016; 5 (08) e003553
    CrossrefPubMedGoogle Scholar
  • 48 Páramo JA, Orbe J, Beloqui O. , et al. Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease. Stroke 2004; 35 (05) 1085-1089
    CrossrefPubMedGoogle Scholar
  • 49 Altman R, Scazziota A, Herrera L, González C. Relationship between thrombin generation and international normalized ratio in patients receiving oral vitamin K antagonist therapy. J Thromb Haemost 2007; 5 (07) 1552-1569
    CrossrefPubMedGoogle Scholar